Moreover, telmisartan or enalapril administered in the acute phase of MI significantly decreased MMP-2 and MMP-9 activity [106], and treatment in patients with MI with valsartan or trandolapril for 12 months resulted in the suppression of MMP-9 plasma levels [107]. This evidence concerns the gene MMP2 and myocardial infarction.